Effects of Roselle (Hibiscus sabdariffa Linn.), a Thai Medicinal Plant, on the Mutagenicity of Various Known Mutagens in Salmonella typhimurium and on Formation of Aberrant Crypt Foci Induced by the Colon Carcinogens Azoxymethane and 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in F344 rats

Becker, 1981, Methylation of liver DNA guanine in hydrazine hepatotoxicity: dose-response and kinetic characteristics of 7-methylguanine and O6-methylguanine formation and persistence in rats, Carcinogenesis, 11, 1181, 10.1093/carcin/2.11.1181

Bertram, 1987, Rationale and strategies for chemoprevention of cancer in humans, Cancer Research, 47, 3012

Bird, 1987, Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings, Cancer Letters, 37, 147, 10.1016/0304-3835(87)90157-1

Bird, 1995, Role of aberrant crypt foci in understanding the pathogenesis of colon cancer, Cancer Letters, 93, 55, 10.1016/0304-3835(95)03788-X

Boone, 1990, Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: a review, Cancer Research, 50, 2

Bull, 1981, Effect of inhibitors of tumorigenesis on the formation of O6-methylguanine in the colon of 1,2–dimethylhydrazine-treated rats, Cancer Research, 41, 4938

Craven, 1985, Fatty acid-stimulated oxidation of methylazoxymethanol by rat colonic mucosa, Cancer Research, 45, 1115

Esumi, 1989, Induction of lymphoma in CDF1 mice by food mutagen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, Japanese Journal of Cancer Research, 80, 1176, 10.1111/j.1349-7006.1989.tb01651.x

Felton, 1986, The isolation and identification of a new mutagen from fried ground beef: 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), Carcinogenesis, 7, 1081, 10.1093/carcin/7.7.1081

Fiala, 1983, Investigations into the mechanism and mode of action of the colon carcinogens 1,2-dimethylhydrazine and azoxymethane, Cancer, 40, 2436, 10.1002/1097-0142(197711)40:5+<2436::AID-CNCR2820400908>3.0.CO;2-U

Fiala, 1991, Mechanism of benzylselenocyanate inhibition of azoxymethane-induced colon carcinogenesis in F344 rats, Cancer Research, 51, 2826

Hasegawa, 1993, Dose-dependence of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) carcinogenicity in rats, Carcinogenesis, 14, 2553, 10.1093/carcin/14.12.2553

Hayatsu, 1988, Dietary inhibitors of mutagenesis and carcinogenesis, Mutation Research, 202, 429, 10.1016/0027-5107(88)90204-7

Hocman, 1989, Prevention of cancer: vegetables and plants, Comparative Biochemistry and Physiology. Part B, Comparative Biochemistry: an International Journal, 93B, 201, 10.1016/0305-0491(89)90070-9

IARC (1993) Cancer in Thailand 1988–1991. IARC Technical Report No. 16, ed. V. Vatanasapt N. Martin, H. Sriplung K. Chindavijak S. Sontipong S. Sriamporn D. M. Parkin and J. Ferlay pp. 64. International Agency for Research on Cancer, Lyon

Ito, 1991, A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine (PhIP), Carcinogenesis, 12, 1503, 10.1093/carcin/12.8.1503

Kawamori, 1995, Suppression of azoxymethane-induced colonic aberrant crypt foci by dietary exposure to a novel synthesized retinoidal butenolide, 5-hydroxy-4-(2-phenyl-(E)ethenyl)-2(5H)-furanone, in rats, Cancer Letters, 92, 159, 10.1016/0304-3835(95)03770-W

Kleman M. I. and Overvik E. (1995) Carcinogens formed during cooking. In Drugs, Diet and Disease, Vol. 1. Mechanistic Approaches to Cancer, ed. C. Ioannides and D. F. V. Lewis, pp. 67–93. Ellis Horwood, London

Lam, 1991, Reduction of aberrant crypt formation in the colon of CF1 mice by potential chemopreventive agents, Carcinogenesis, 12, 2311, 10.1093/carcin/12.12.2311

Layton, 1995, Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research, Carcinogenesis, 16, 39, 10.1093/carcin/16.1.39

McLellan, 1991, Effect of disulfiram on 1,2-dimethylhydrazine- and azoxymethane-induced aberrant crypt foci, Carcinogenesis, 12, 969, 10.1093/carcin/12.6.969

Manson M. M. (1995) Aflatoxins. In Molecular and Cellular Mechanism of Toxicity, ed. F. D. Matteis and L. L. Smith, pp. 69–83. CRC Press, New York

Maron, 1983, Revised methods for the Salmonella mutagenicity test, Mutation Research, 113, 173, 10.1016/0165-1161(83)90010-9

Morse, 1993, Cancer chemoprevention: principles and prospects, Carcinogenesis, 14, 1737, 10.1093/carcin/14.9.1737

Ochiai, 1996, Efficient method for rapid induction of aberrant crypt foci in rats with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, Japanese Journal of Cancer Research, 87, 1029, 10.1111/j.1349-7006.1996.tb03105.x

Pereira, 1994, Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents, Carcinogenesis, 15, 1049, 10.1093/carcin/15.5.1049

Pereira, 1991, Prevention by chemopreventive agents of azoxymethane-induced foci of aberrant crypts in rat colon, Cancer Letters, 61, 27, 10.1016/0304-3835(91)90073-Q

Pretlow, 1991, Aberrant crypts: putative preneoplastic foci in human colonic mucosa, Cancer Research, 51, 1564

Pretlow, 1992, Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate, Carcinogenesis, 13, 1509, 10.1093/carcin/13.9.1509

Shivapurkar, 1995, Inhibition of progression of aberrant crypt foci and colon tumor development by vitamin E and β-carotene in rats on a high-risk diet, Cancer Letters, 91, 125, 10.1016/0304-3835(95)03729-G

Sohn, 1991, Metabolism of azoxymethane, methylazoxymethanol and N-nitrosodimethylamine by cytochrome P450 IIE1, Carcinogenesis, 12, 127, 10.1093/carcin/12.1.127

Stopera, 1992, Expression of ras oncogene mRNA and protein in aberrant crypt foci, Carcinogenesis, 13, 1863, 10.1093/carcin/13.10.1863

Stopera, 1992, Colonic aberrant crypt foci are associated with increased expression of c-fos: the possible role of modified c-fos expression in preneoplastic lesions in colon cancer, Carcinogenesis, 13, 573, 10.1093/carcin/13.4.573

Sugimura, 1983, Mutagens-carcinogens in foods, Cancer Research, 43, 2415s

Tachino, 1995, Evidence for ras gene mutation in 2-amino-3-methylimidazo[4,5-f]quinoline-induced colonic aberrant crypts in the rat, Molecular Carcinogenesis, 12, 187, 10.1002/mc.2940120402

Takahashi, 1997, Reduction in formation of 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP)-induced aberrant crypt foci in the rat colon by docosahexaenoic acid (DHA), Carcinogenesis, 18, 1937, 10.1093/carcin/18.10.1937

Takahashi, 1991, Induction of aberrant crypt foci in the large intestine of F344 rats by oral administration of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, Japanese Journal of Cancer Research, 82, 135, 10.1111/j.1349-7006.1991.tb01819.x

Tudek, 1989, Foci of aberrant crypts in the colons of mice and rats exposed to carcinogens associated with foods, Cancer Research, 49, 1236

Utsunomiya, 1993, Comparison of colorectal cancer in Japan and USA, Karkinos, 6, 839

Vivona, 1993, K-ras mutations in aberrant crypt foci, adenomas and adenocarcinomas during azoxymethane-induced colon carcinogenesis, Carcinogenesis, 14, 1777, 10.1093/carcin/14.9.1777

Wattenberg, 1985, Chemoprevention of cancer, Cancer Research, 45, 1

Wattenberg L. W. (1992) Chemoprevention of cancer by naturally occurring and synthetic compounds. In Cancer Chemoprevention, ed. L. Wattenberg, M. Lipkin, C. W. Boone and G. J. Kelloff, pp. 19–40. CRC Press, Boca Raton, FL

Weisburger, 1971, Colon carcinogens: their metabolism and mode of action, Cancer, 28, 60, 10.1002/1097-0142(197107)28:1<60::AID-CNCR2820280113>3.0.CO;2-U